Graham Capital Management, L.P. Penumbra Inc Transaction History

Graham Capital Management, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$172.27 - $223.95 $323,006 - $419,906	-1,875 Reduced 45.28%	2,266 $407,000
Q1 2024 May 15, 2024	SELL	$220.09 - $273.15 $596,223 - $739,963	-2,709 Reduced 39.55%	4,141 $924,000
Q4 2023 Feb 14, 2024	BUY	$181.44 - $260.22 $993,384 - $1.42 Million	5,475 Added 398.18%	6,850 $1.72 Million
Q3 2023 Nov 22, 2023	SELL	$240.69 - $338.77 $76,058 - $107,051	-316 Reduced 18.69%	1,375 $332,000
Q2 2023 Aug 14, 2023	BUY	$271.54 - $344.06 $459,174 - $581,805	1,691 New	1,691 $581,000
Q4 2022 Feb 14, 2023	SELL	$151.88 - $228.5 $265,638 - $399,646	-1,749 Reduced 44.72%	2,162 $480,000
Q3 2022 Nov 14, 2022	SELL	$120.36 - $205.88 $982,137 - $1.68 Million	-8,160 Reduced 67.6%	3,911 $741,000
Q2 2022 Aug 15, 2022	BUY	$116.09 - $227.33 $1.09 Million - $2.14 Million	9,399 Added 351.76%	12,071 $1.5 Million
Q1 2022 May 16, 2022	BUY	$187.51 - $283.98 $501,026 - $758,794	2,672 New	2,672 $593,000

372

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.28B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.